Share on LinkedInShare on LinkedIn

ARTICLE · 23 NOVEMBER 2010

Intellectual Property Weekly Abstracts Alert (Week of November 15th, 2010)

Borden Ladner Gervais LLP
Borden Ladner Gervais LLP
Contributor
Borden Ladner Gervais LLP

Borden Ladner Gervais LLP

With over 750 lawyers, intellectual property agents and other professionals, BLG services...

View firm profile
Explore more from Borden Ladner Gervais LLP

In this proceeding under the "NOC Regulations", the Court found all of Apotex’ allegations to be unjustified. However, the proceeding was dismissed for mootness, as the patent at issue had been found invalid "in rem", in an impeachment action.

CanadaIntellectual Property

Editors: Chantal Saunders and Beverley Moore

NOC PROCEEDINGS

Court Finds Allegations in NOA to be Unjustified, However Dismisses Application for Prohibition on basis of Mootness

Eli Lilly v. Apotex
Drug: atomoxetine

In this proceeding under the NOC Regulations, the Court found all of Apotex' allegations to be unjustified. However, the proceeding was dismissed for mootness, as the patent at issue had been found invalid in rem, in an impeachment action.

The Court considered Apotex' allegations of obviousness and anticipation and found that they were not justified.

The Court then considered the issue of utility. The Court found that in its evidence, Apotex had focussed on the allegation of a lack of sound prediction. However, the Court held that Lilly asserted that the patent demonstrated utility. Lilly tendered as evidence a report and the published version of a clinical trial study as exhibits to an expert affidavit. Apotex sought to challenge the

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from